1. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment 
M.H. Wernitz, S. Keck, S. Swidsinski, S. Schulz, S.K. Veit 
Clinical Microbiology and Infection 
Volume 11, Issue 6, Pages (June 2005)
DOI: /j x
Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Sensitivity analysis for the incidence rate of MRSA carriage at hospital admission. The screening programme becomes cost-effective at the intercept points (break-even points) between the black straight line and the dashed straight lines. If a hospital decides not to operate a screening programme, the costs indicated by the black straight line correspond to the costs required to treat the hospital-acquired MRSA infections that may otherwise have been prevented. The costs for the different screening frequencies apply to a hospital setting with 700 beds and c inpatients annually.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions